Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Asset Acquisition [Table] Asset Acquisition [Table] Maximum Maximum [Member] Cash acquired in connection with the reverse recapitalization Reverse Recapitalization, Cash Acquired Reverse Recapitalization, Cash Acquired Statistical Measurement [Domain] Statistical Measurement [Domain] Recapitalization exchange ratio Recapitalization Exchange Ratio Recapitalization Exchange Ratio Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Loss Allocation, Diluted Net Income (Loss) Available to Common Stockholders, Diluted Document Fiscal Year Focus Document Fiscal Year Focus Operating lease, discount rate Lessee, Operating Lease, Discount Rate Adjustment to Compensation, Amount Adjustment to Compensation Amount Net loss per share attributable to Series A non-voting convertible preferred shareholders, diluted (in dollars per share) Loss Per Share, Diluted (in dollars per share) Undistributed Earnings (Loss) Allocated To Participating Securities Per Share, Diluted Undistributed Earnings (Loss) Allocated To Participating Securities Per Share, Diluted Number of RSUs Number of RSAs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Segment Reporting [Abstract] Ordinary shares, $0.001 par value; 175,000,000 shares authorized as of June 30, 2026 and December 31, 2025, 27,756,044 and 27,556,767 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of RSU and RSA activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Accrued employee compensation and benefits Employee-related Liabilities, Current Paragon Option Agreements Paragon Option Agreements [Member] Paragon Option Agreements Loss contingency liability Loss Contingency Accrual Restatement Determination Date Restatement Determination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Warrants, exercisable (in shares) Pre-funded warrants, shares purchasable (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Exchange of Series Seed convertible preferred stock for Series A designated non-voting convertible preferred shares upon the closing of the reverse recapitalization (in shares) Temporary Equity, Shares, Conversion of Convertible Securities Temporary Equity, Shares, Conversion of Convertible Securities Amendment Flag Amendment Flag Current liabilities Liabilities, Current [Abstract] Project [Axis] Project [Axis] Shares issued upon conversion (in shares) Conversion of Stock, Shares Converted Related party accounts payable and other current liabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Automatic stock plan increase, percent of diluted stock Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Authorized, Annual Percentage Increase Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Authorized, Annual Percentage Increase Disposal Group Classification [Axis] Disposal Group Classification [Axis] Loss Contingencies [Table] Loss Contingencies [Table] Weighted-average ordinary shares outstanding used in computing net loss per share to ordinary shareholders, basic (in shares) Weighted Average Shares Outstanding, Basic (in shares) Weighted Average Number of Shares Outstanding Available To Common Stockholders, Basic Weighted Average Number of Shares Outstanding Available To Common Stockholders, Basic Leases [Abstract] Milestone and license fees Milestone And License Fees Milestone And License Fees Related Party Transactions Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Schedule of cash and cash equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Entity Address, State or Province Entity Address, State or Province Option agreement, termination period Option Agreement, Termination Period Option Agreement, Termination Period Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Cash and Cash Equivalents [Abstract] Long term liabilities Liabilities, Noncurrent [Abstract] Unvested beginning balance (in shares) Unvested ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Tranche One Share-Based Payment Arrangement, Tranche One [Member] Schedule of fair value of warrants Share-Based Payment Arrangement, Activity [Table Text Block] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Debt instrument, increase limit Debt Instrument, Accordion Feature, Increase Limit Debt Instrument, Accordion Feature, Increase Limit Parascent Holding LLC Parascent Holding LLC [Member] Parascent Holding LLC Entity Address, City or Town Entity Address, City or Town Consideration transferred Asset Acquisition, Consideration Transferred RSUs granted in shares) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Shares vested (in shares) Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Loss Allocation, Basic Net Income (Loss) Available to Common Stockholders, Basic Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Interest income Investment Income, Nonoperating License License [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Release of restricted stock units (in shares) Shares issued (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recently Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities Capital Expenditures Incurred but Not yet Paid Deferred revenue Increase (Decrease) in Contract with Customer, Liability Schedule of segment loss, including significant segment expenses Segment Reporting [Table Text Block] Prepaid research and development services Prepaid Research And Development Expense, Current Prepaid Research And Development Expense, Current Other liabilities assumed in connection with the reverse recapitalization Noncash or Part Noncash Acquisition, Value of Liabilities Assumed Use of Estimates Use of Estimates, Policy [Policy Text Block] License Agreements Asset Acquisition [Text Block] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Schedule of accrued expenses and other current liabilities Schedule of Accrued Liabilities [Table Text Block] Schedule of changes in fair value for warrant liability Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Research and Development Contract Costs Accruals Research and Development Expense, Policy [Policy Text Block] Weighted-average ordinary shares outstanding used in computing net loss per share to ordinary shareholders, diluted (in shares) Weighted Average Shares Outstanding, Diluted (in shares) Weighted Average Number of Shares Outstanding Available To Common Stockholders, Diluted Weighted Average Number of Shares Outstanding Available To Common Stockholders, Diluted Development milestone payment Asset Acquisition, Development Milestone Payments, Maximum Asset Acquisition, Development Milestone Payments, Maximum Estimated purchase price warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Restriction period Asset Acquisition, License Agreement, Restriction Period Asset Acquisition, License Agreement, Restriction Period Schedule of total remaining operating lease payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Forfeited and expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, stock outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Shares Outstanding (in shares) Preferred Stock, Shares Outstanding Convertible notes payable Debt Instrument, Face Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Number of employees overseeing and coordinating the project Asset Acquisition, Number Of Employees Overseeing And Coordinating Research Project Asset Acquisition, Number Of Employees Overseeing And Coordinating Research Project Share-Based Compensation Equity [Text Block] Beginning balance, Convertible Preferred Stock (in shares) Ending balance, Convertible Preferred Stock (in shares) Temporary Equity, Shares Outstanding Security Exchange Name Security Exchange Name Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Combination study approval payment Contract With Customer, Collaborative Arrangement, Combination Study Approval Payment Contract With Customer, Collaborative Arrangement, Combination Study Approval Payment Issuance costs of Pre-closing financing and reverse recapitalization Adjustments to Additional Paid in Capital, Issuance Costs Of Financing And Reverse Recapitalization Adjustments to Additional Paid in Capital, Issuance Costs Of Financing And Reverse Recapitalization Fair value of shares vested Fair value of shares vested (less than for the six months ended June 30, 2026) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Entity Shell Company Entity Shell Company Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Number of shares authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Operating lease liability, current Operating Lease, Liability, Current Net Loss per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Reverse Recapitalization Of GlycoMimetics Reverse Recapitalization Of GlycoMimetics [Member] Reverse Recapitalization Of GlycoMimetics Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Geographical [Domain] Geographical [Domain] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation cost, stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Schedule of cash and restricted cash Restrictions on Cash and Cash Equivalents [Table Text Block] Income Tax Disclosure [Abstract] Supplemental disclosure of non-cash operating and financing activities: Noncash Investing and Financing Items [Abstract] Low-single digits to low-double digits royalty payment, period Asset Acquisition, Sale Based Milestone Payment, Low-Single Digits To Low-Double Digits Royalty Payment, Period Asset Acquisition, Sale Based Milestone Payment, Low-Single Digits To Low-Double Digits Royalty Payment, Period Ownership percentage (less than for Paragon and Parascent, and more than for Fairmount) (in percent) Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage Related Party Transactions [Abstract] Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Percent of net sales, royalty payment (less than) Option Agreement, Royalty Payment, Percent Of Net Sales Option Agreement, Royalty Payment, Percent Of Net Sales Individual: Individual [Axis] Warrant Warrant [Member] 2025 Employment Inducement Incentive Award Plan 2025 Employment Inducement Incentive Award Plan [Member] 2025 Employment Inducement Incentive Award Plan Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Disposal Group Name [Domain] Disposal Group Name [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Convertible Note Purchase Agreement Convertible Note Purchase Agreement [Member] Convertible Note Purchase Agreement Personnel costs Personnel Costs Personnel Costs Convertible Preferred Stock Series Seed Convertible Preferred Stock Series Seed Convertible Preferred Stock [Member] Series Seed Convertible Preferred Stock Award Timing Predetermined Award Timing Predetermined [Flag] Project [Domain] Project [Domain] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Issuance of ordinary shares and pre-funded warrants in the Pre-Closing financing Stock And Warrants Issued During Period, Value, Reverse Recapitalization Stock And Warrants Issued During Period, Value, Reverse Recapitalization Termination period due to breach of contract Asset Acquisition, Option Agreement Termination Period, Breach Of Contract Asset Acquisition, Option Agreement Termination Period, Breach Of Contract Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Level 1 Fair Value, Inputs, Level 1 [Member] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Pre-Merger Sale of Common Stock and Warrants Pre-Merger Sale Of Common Stock And Warrants [Member] Pre-Merger Sale Of Common Stock And Warrants Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Area of office space (in sqft) Area of Real Estate Property Crescent Biopharma Crescent Biopharma [Member] Crescent Biopharma Unvested beginning balance (in dollars per share) Unvested ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Repurchase and cancellation of restricted stock awards Stock Repurchased and Retired During Period, Value Operating lease liability Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Depreciation expense Depreciation Vesting [Domain] Vesting [Domain] Plan Name [Domain] Plan Name [Domain] Maximum percentage ownership after exercise Class Of Warrant Or Right, Exercisable Condition, Maximum Percentage Ownership After Exercise Class Of Warrant Or Right, Exercisable Condition, Maximum Percentage Ownership After Exercise Antidilutive Securities [Axis] Antidilutive Securities [Axis] Scenario [Domain] Scenario [Domain] Number of votes Asset Acquisition, Number Of Votes, Option Agreement Asset Acquisition, Number Of Votes, Option Agreement Beginning balance outstanding (in dollars per share) Ending balance outstanding (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Other prepaid expenses and other current assets Other Prepaid Expenses And Other Current Assets Other Prepaid Expenses And Other Current Assets Non-refundable milestone payments Asset Acquisition, Maximum Aggregate Milestone Payments Asset Acquisition, Maximum Aggregate Milestone Payments Schedule of basic and diluted net loss per share attributable to ordinary shareholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Segment Reporting Segment Reporting [Text Block] Expiration Date Trading Arrangement Expiration Date Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Location, Statement of Income, Balance [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Building Building [Member] Nonrelated Party Nonrelated Party [Member] Disposal Group, Including Discontinued Operations [Line Items] Disposal Group, Including Discontinued Operations [Line Items] Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Common stock, authorized (in shares) Common Stock, Shares Authorized Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Number of shares issued and sold (in shares) Sale of Stock, Number of Shares Issued in Transaction Exercise Price Award Exercise Price Assets acquired in connection with the reverse recapitalization Noncash or Part Noncash Acquisition, Value of Assets Acquired Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Remaining lease term Lessee, Operating Lease, Remaining Lease Term Segment Reporting [Line Items] Segment Reporting [Line Items] Proceeds received from sale of assets Proceeds from Sales of Assets, Investing Activities Document Quarterly Report Document Quarterly Report Cell Line License Agreement Cell Line License Agreement [Member] Cell Line License Agreement Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Convertible Notes Payable Debt Disclosure [Text Block] Interest payable Interest Payable Scenario [Axis] Scenario [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Weighted-average Series A non-voting convertible preferred shares outstanding used in computing net loss per share to Series A non-voting convertible preferred shareholders, diluted (in shares) Weighted Average Shares Outstanding, Diluted (in shares) Weighted Average Number of Shares Outstanding Allocated To Participating Securities, Diluted Weighted Average Number of Shares Outstanding Allocated To Participating Securities, Diluted Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Contract with customer, refund liability Contract with Customer, Refund Liability License Agreement Terms License Agreement Terms [Member] Stock converted (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Consideration received Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Counterparty Name [Domain] Counterparty Name [Domain] Accrue interest rate Debt Instrument, Interest Rate, Stated Percentage Total shareholders' equity Beginning balance Ending balance Equity, Attributable to Parent Other expense (income) Nonoperating Income (Expense) Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Net loss per share attributable to ordinary shareholders, basic (in dollars per share) Loss Per Share, Basic (in dollars per share) Net Income (Loss) Available To Common Stockholders Per Share, Basic Net Income (Loss) Available To Common Stockholders Per Share, Basic Option agreement termination period, maximum contractual period Asset Acquisition, Option Agreement Termination Period, Maximum Contractual Period Asset Acquisition, Option Agreement Termination Period, Maximum Contractual Period Vesting of early exercised stock options APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Net loss per share attributable to ordinary shareholders, diluted (in dollars per share) Loss Per Share, Diluted (in dollars per share) Net Income (Loss) Available To Common Stockholders Per Share, Diluted Net Income (Loss) Available To Common Stockholders Per Share, Diluted Total present value of operating lease liability Operating Lease, Liability Professional and other fees Professional Fees Insider Trading Policies and Procedures [Line Items] Beginning balance outstanding (in shares) Ending balance outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accrued Expenses and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Other income Other Operating Income Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Business Combination [Domain] Business Combination [Domain] Aggregate gross proceeds Sale of Stock, Consideration Received Per Transaction Forfeited and expired (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Convertible note principal and non-cash accrued interest converted to ordinary shares Noncash Or Part Noncash Acquisition, Accrued Interest, Convertible Note Converted To Common Stock Noncash Or Part Noncash Acquisition, Accrued Interest, Convertible Note Converted To Common Stock Sales Agreement Sales Agreement [Member] Sales Agreement Antidilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted Stock Units (RSUs) RSUs Outstanding unvested restricted stock units Restricted Stock Units (RSUs) [Member] Schedule of anti-dilutive net loss per share attributable to ordinary shareholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key All Adjustments to Compensation All Adjustments to Compensation [Member] Equity [Abstract] Business Combination [Axis] Business Combination [Axis] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Liquidation Preference Preferred Stock, Liquidation Preference, Value Net cash used in operating activities Cash used for operating activity Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Class of warrant or right issue price (in dollars per share) Class Of Warrant Or Right, Issue Price Class Of Warrant Or Right, Issue Price Indemnification Agreement Indemnification Agreement [Member] Income Statement [Abstract] Shares issued during period (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Ownership [Axis] Ownership [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of weighted-average assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] City Area Code City Area Code RSAs Outstanding unvested restricted stock awards Restricted Stock [Member] All Individuals All Individuals [Member] Subsequent Events Subsequent Events [Text Block] Non-cash lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Collaborative Arrangement Collaborative Arrangement [Member] Name Forgone Recovery, Individual Name Unrecognized compensation cost, weighted average period of recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Commitments and Contingencies Commitments and Contingencies, Policy [Policy Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Accrued research and development Accrued Research And Development, Current Accrued Research And Development, Current Statement [Line Items] Statement [Line Items] Total assets Assets Entity [Domain] Entity [Domain] Preferred stock, stock issued (in shares) Preferred Shares Issued (in shares) Preferred Stock, Shares Issued Common stock reserved for issuance of conversion shares (in shares) Common Stock, Capital Shares Reserved for Future Issuance Research and Development, Contract to Perform for Others [Table] Research and Development, Contract to Perform for Others [Table] Convertible preferred stock, issued (in shares) Temporary Equity, Stock Issued During Period, Shares, New Issues Temporary Equity, Stock Issued During Period, Shares, New Issues Weighted average grant-date fair value of stock options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Interest expense Interest expense Interest Expense, Nonoperating Schedule of share-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Proceeds from issuance of shares under employee stock purchase plan Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Issuance of ordinary shares under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Other assets Increase (Decrease) in Other Operating Assets Related party accounts payable and other current liabilities Accounts payable and other current liabilities Accounts Payable and Other Accrued Liabilities, Current PEO PEO [Member] Accrued withholding taxes Accrual for Taxes Other than Income Taxes, Current Warrants converted (in shares) Warrants Converted, Reverse Recapitalization Warrants Converted, Reverse Recapitalization Total share-based compensation expense Share-Based Payment Arrangement, Expense Convertible preferred stock, conversion ratio Preferred Stock, Convertible, Conversion Ratio Repurchase and cancellation of restricted stock awards (in shares) Stock Repurchased and Retired During Period, Shares Number of additional shares authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Early exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period 2024 Equity Incentive Plan 2024 Equity Incentive Plan [Member] 2024 Equity Incentive Plan Weighted average grant date fair value (in dollars per share) Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Exchange of Series Seed convertible preferred stock for Series A designated non-voting convertible preferred shares upon the closing of the reverse recapitalization Temporary Equity, Value, Conversion of Convertible Securities Temporary Equity, Value, Conversion of Convertible Securities Contract with customer, liability, revenue recognized Contract with Customer, Liability, Revenue Recognized Underwriting Agreement Underwriting Agreement [Member] Underwriting Agreement Subsequent Event Type [Domain] Subsequent Event Type [Domain] Kelun-Biotech Kelun-Biotech [Member] Kelun-Biotech Payables and Accruals [Abstract] Accumulated Deficit Retained Earnings [Member] Operating lease liability, noncurrent Operating Lease, Liability, Noncurrent Total operating expenses Operating Expenses Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Non-Voting Preferred Shares Series A Preferred Stock Series A Preferred Stock [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Payment of deferred offering costs Payment Of Deferred Offering Costs Payment Of Deferred Offering Costs Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Repurchase of equity awards Debt issuance costs (less than) Payments of Debt Issuance Costs Entity Current Reporting Status Entity Current Reporting Status Net cash (used in) provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Accrued expenses and other current liabilities Accrued Expenses And Other Accrued Liabilities, Current Accrued Expenses And Other Accrued Liabilities, Current Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Ownership [Domain] Ownership [Domain] Losses incurred to date Loss Contingency, Losses Incurred To Date Loss Contingency, Losses Incurred To Date Research and development Research and development Research and development expense Research and Development Expense Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Reportable Segment Reportable Segment [Member] Reportable Segment Weighted-average number of shares of as-converted (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Share-Based Payment Arrangement [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] License agreement revenue Revenue from Contract with Customer, Excluding Assessed Tax Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Percent reduction to royalty payment due to invalid patent Asset Acquisition, Royalty Percent Paid, Reduction Due To Invalid Patent Asset Acquisition, Royalty Percent Paid, Reduction Due To Invalid Patent Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Over-Allotment Option Over-Allotment Option [Member] Discovery external research and development costs Discovery External Research And Development Costs [Member] Discovery External Research And Development Costs Pre-Funded Warrant Pre-Funded Warrant [Member] Pre-Funded Warrant Non-Voting Preferred Shares Preferred Stock [Member] Sublicense agreement period Asset Acquisition, Option Agreement Sublicense Agreement Period Asset Acquisition, Option Agreement Sublicense Agreement Period SKB105 SKB105 [Member] SKB105 Segment Reporting [Table] Segment Reporting [Table] Number of shares available for future awards (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Related Party Transaction [Table] Related Party Transaction [Table] Sale of Stock [Axis] Sale of Stock [Axis] Stock Options, Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Total prepaid expenses and other current assets Other Assets, Current Commitments and Contingencies Disclosure [Abstract] Other income (expense): Other Nonoperating Income (Expense) [Abstract] All Trading Arrangements All Trading Arrangements [Member] Financial liability (less than) Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date PIPE Financing PIPE Financing [Member] PIPE Financing Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Issuance of convertible preferred stock Temporary Equity, Stock Issued During Period, Value, New Issues Warrants exercised (in shares) Class Of Warrant Or Right, Exercised Class Of Warrant Or Right, Exercised Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of stock option activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Deferred financing costs included in accounts payable and accrued expenses and other current liabilities Deferred Financing Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities Deferred Financing Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Prepaid Expenses and Other Current Assets Other Assets Disclosure [Text Block] Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Related Party Related Party [Member] Class of Stock [Line Items] Class of Stock [Line Items] Percent of outstanding shares Class Of Warrants Or Rights, Percent Of Outstanding Shares Class Of Warrants Or Rights, Percent Of Outstanding Shares Entity Interactive Data Current Entity Interactive Data Current Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Expense related to 401(k) Plan match contributions Defined Contribution Plan, Cost Entity Small Business Entity Small Business Net loss and comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Common stock, number of votes Common Stock, Number Of Votes Common Stock, Number Of Votes Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Subsequent Events [Abstract] Issuance of warrant Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Asset Sale Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Award expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Other assets Other Assets, Noncurrent Document Type Document Type Total accrued expenses and other current liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Basis of Presentation and Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Gain on sale of assets Gain (Loss) on Disposition of Assets Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Exercisable aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Total Paragon expenses Operating Costs and Expenses Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Registrant Name Entity Registrant Name Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Non-cash interest expense Non-cash interest expense Interest Expense, Other Vested and expected to vest aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Commitments and contingencies (Note 13) Commitments and Contingencies Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] GMI-1687 and GMI-1271 Technology GMI-1687 and GMI-1271 Technology [Member] GMI-1687 and GMI-1271 Technology Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Counterparty Name [Axis] Counterparty Name [Axis] Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Exercisable weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Beginning balance, Convertible Preferred Stock Ending balance, Convertible Preferred Stock Temporary Equity, Carrying Amount, Attributable to Parent Schedule of financial assets carried at fair value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] All Award Types Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount 2026 (remainder of the year) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term License Agreement [Axis] License Agreement [Axis] License Agreement Lease term Lessee, Operating Lease, Term of Contract PEO Name PEO Name Geographical [Axis] Geographical [Axis] Percent of outstanding common stock, on a fully diluted basis Class Of Warrants Or Rights, Percent Of Outstanding Shares, Fully Diluted Basis Class Of Warrants Or Rights, Percent Of Outstanding Shares, Fully Diluted Basis Restricted cash Restricted Cash Option agreement termination period due to breach of contract Option Agreement, Termination Period, Breach Of Contract Option Agreement, Termination Period, Breach Of Contract Contract with customer, liability Contract with Customer, Liability Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] CR-002 CR-002 external research and development costs CR-002 [Member] CR-002 Entity Tax Identification Number Entity Tax Identification Number Legal Entity [Axis] Legal Entity [Axis] Sale of stock, amount authorized Sale Of Stock, Amount Authorized Sale Of Stock, Amount Authorized Liability Class [Axis] Liability Class [Axis] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Net loss per share attributable to Series A non-voting convertible preferred shareholders, basic (in dollars per share) Loss Per Share, Basic (in dollars per share) Undistributed Earnings (Loss) Allocated To Participating Securities Per Share, Basic Undistributed Earnings (Loss) Allocated To Participating Securities Per Share, Basic Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash shown in the statements of cash flows Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Accrued professional and consulting Accrued Professional Fees, Current Accounts payable Increase (Decrease) in Accounts Payable Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Nature of the Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Subsequent Event [Table] Subsequent Event [Table] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Disposal Group Name [Axis] Disposal Group Name [Axis] Number of exercisable shares (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities ESPP Employee Stock [Member] Leases Lessee, Operating Leases [Text Block] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] WuXi Biologics Ireland Limited WuXi Biologics Ireland Limited [Member] WuXi Biologics Ireland Limited Deferred revenue Deferred Revenue Deferred revenue Deferred revenue, current Contract with Customer, Liability, Current Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Consideration transfer, period Contract With Customer, Collaborative Arrangement, Consideration Transferred, Period Contract With Customer, Collaborative Arrangement, Consideration Transferred, Period Paragon Therapeutics Paragon Therapeutics [Member] Paragon Therapeutics Option agreement termination period due to failure to pay Option Agreement, Termination Period, Failure To Pay Option Agreement, Termination Period, Failure To Pay Award Type Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Issuance of Parascent warrants Adjustments to Additional Paid in Capital, Warrant Issued Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Restricted cash Restricted Cash, Noncurrent Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Ordinary Shares Ordinary Shares Outstanding and issued common stock options Common Stock [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Issuance of common stock and pre-funded warrants in the Pre-Closing financing (in shares) Stock And Warrants Issued During Period, Shares, Reverse Recapitalization Stock And Warrants Issued During Period, Shares, Reverse Recapitalization Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Percent of award vesting rights Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights, Quarterly Percentage, Remainder Of Period Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights, Quarterly Percentage, Remainder Of Period Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Vesting of early exercised stock options Vesting Of Early Exercised Stock Options Vesting Of Early Exercised Stock Options Equity Awards Adjustments Equity Awards Adjustments [Member] Asset Acquisition [Line Items] Asset Acquisition [Line Items] Total liabilities and shareholders’ equity Liabilities and Equity Sale based milestone payment Asset Acquisition, Sales-Based Milestone Payments, Maximum Asset Acquisition, Sales-Based Milestone Payments, Maximum Stock options Share-Based Payment Arrangement, Option [Member] Ordinary Shares Issuable Upon Conversion (in shares) Preferred Stock, Convertible, Shares Issuable Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Mid-single digits to low-double digits royalty payment, period Asset Acquisition, Sale Based Milestone Payment, Mid-Single Digits To Low-Double Digits Royalty Payment, Period Asset Acquisition, Sale Based Milestone Payment, Mid-Single Digits To Low-Double Digits Royalty Payment, Period Plan Name [Axis] Plan Name [Axis] Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Waltham, Massachusetts Waltham, Massachusetts [Member] Waltham, Massachusetts Tabular List, Table Tabular List [Table Text Block] Vesting [Axis] Vesting [Axis] Additional paid-in capital Additional Paid in Capital 2025 Employee Stock Purchase Plan 2025 Employee Stock Purchase Plan [Member] 2025 Employee Stock Purchase Plan Schedule of convertible preferred stock Schedule of Conversions of Stock [Table Text Block] Purchase of research and development license Payments to Acquire Intangible Assets Total other income (expense) Other Nonoperating Income (Expense) Schedule of related party accounts payable and other current liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Name Awards Close in Time to MNPI Disclosures, Individual Name Shareholders’ equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Beginning balance outstanding aggregate intrinsic value Ending balance outstanding aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period General and administrative General and administrative expense General and Administrative Expense Loss Allocation, Diluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Estimated purchase price (in dollars per share) Sale of Stock, Price Per Share Conversion of convertible securities Stock Issued During Period, Value, Conversion of Convertible Securities Preferred stock, stock authorized (in shares) Preferred Shares Authorized (in shares) Preferred Stock, Shares Authorized Schedule of expenses related to development costs Research and Development Arrangement, Contract to Perform for Others [Table Text Block] Non-voting convertible preferred shares, $0.001 par value; 5,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 2,890 Series A designated shares issued and outstanding as of June 30, 2026 and December 31, 2025 Carrying Value Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Accrued interest Interest Paid, Excluding Capitalized Interest, Operating Activity Statement of Cash Flows [Abstract] Loss Allocation, Basic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total Assets Assets, Fair Value Disclosure Fairmount Healthcare Fund II L.P. Fairmount Healthcare Fund II L.P. [Member] Fairmount Healthcare Fund II L.P. Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Discontinued Operations and Disposal Groups [Abstract] Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Proceeds from sale of intangible assets Proceeds from Sale of Intangible Assets Notice period Sale Of Stock, Percentage Of Ownership After Transaction, Notice Period Sale Of Stock, Percentage Of Ownership After Transaction, Notice Period Maximum percentage ownership after exercise, upon 61 days notice Class Of Warrant Or Right, Exercisable Condition, Maximum Percentage Ownership After Exercise, Upon 61 Days Notice Class Of Warrant Or Right, Exercisable Condition, Maximum Percentage Ownership After Exercise, Upon 61 Days Notice Name Trading Arrangement, Individual Name Unrecognized compensation cost, other awards Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Non-cash exchange of Pre-Merger Crescent Series Seed Preferred Stock for Series A Non-Voting Convertible Preferred Shares Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Company Selected Measure Amount Company Selected Measure Amount Parascent Warrant Parascent Warrant [Member] Parascent Warrant Vested and expected to vest weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Stock, Class of Stock [Table] Stock, Class of Stock [Table] Convertible Preferred Shares and Shareholders' Equity (Deficit) Convertible Preferred Shares And Shareholders' Equity (Deficit) [Text Block] Convertible Preferred Shares And Shareholders' Equity (Deficit) Current assets: Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Operating lease liability arising from obtaining operating right-of-use asset Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Income Tax Expense (Benefit) Income Tax Expense (Benefit) License Agreement [Domain] License Agreement [Domain] License Agreement [Domain] Weighted-average Series A non-voting convertible preferred shares outstanding used in computing net loss per share to Series A non-voting convertible preferred shareholders, basic (in shares) Weighted Average Shares Outstanding, Basic (in shares) Weighted Average Number of Shares Outstanding Allocated To Participating Securities, Basic Weighted Average Number of Shares Outstanding Allocated To Participating Securities, Basic Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Convertible Notes Payable Convertible Notes Payable [Member] Award Timing Method Award Timing Method [Text Block] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Net (decrease) increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forecast Forecast [Member] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Development milestone payments Contract With Customer, Collaborative Arrangement, Development Milestone Payments, Maximum Contract With Customer, Collaborative Arrangement, Development Milestone Payments, Maximum Milestone payment Asset Acquisition, Maximum Aggregate, Milestone Payments 1 Asset Acquisition, Maximum Aggregate, Milestone Payments 1 Net loss and comprehensive loss Net loss Net loss Net income (loss) attributable to parent Net Income (Loss) Attributable to Parent Debt instrument, higher borrowing capacity option Debt Instrument, Accordion Feature, Higher Borrowing Capacity Option Debt Instrument, Accordion Feature, Higher Borrowing Capacity Option Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Location, Statement of Financial Position, Balance [Axis] Location, Statement of Financial Position, Balance [Axis] Statement [Table] Statement [Table] CR-001 CR-001 external research and development costs CR-001 [Member] CR-001 Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] 2025 Stock Incentive Plan 2025 Stock Incentive Plan [Member] 2025 Stock Incentive Plan Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from early exercise of options Proceeds from Stock Options Exercised Proceeds from the Pre-Closing Financing, net Proceeds From Reverse Recapitalization Financing, Net Proceeds From Reverse Recapitalization Financing, Net Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Convertible preferred stock, purchase price (in dollars per share) Temporary Equity, Stock Issued During Period, Value, New Issues, Price Per Share Temporary Equity, Stock Issued During Period, Value, New Issues, Price Per Share Deposit liability Contract With Customer, Deposit Liability, Current Contract With Customer, Deposit Liability, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Percentage of aggregate gross proceeds from each sale of shares Percentage Of Aggregate Gross Proceeds From Each Sale Of Shares Percentage Of Aggregate Gross Proceeds From Each Sale Of Shares Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]